Philip Jonsson is a senior life-sciences leader with 11 years of experience translating computational biology and molecular research into drug discovery programs, now serving as Senior Director at Eli Lilly. His career spans high-impact roles at Lilly/ Loxo Oncology, Scorpion Therapeutics, Celsius Therapeutics, and Memorial Sloan Kettering, blending hands-on computational biology with people leadership and program delivery. He holds a Ph.D. in Cell and Molecular Biology and a cross-disciplinary academic background from KTH, Virginia Tech and Stockholm University, reflecting both deep wet-lab training and quantitative insight. Known for navigating transitions between academia and industry, he brings a pragmatic mix of scientific rigor and operational focus to advance therapeutic pipelines. An international profile and varied training suggest strong adaptability and an ability to connect diverse teams across discovery and development.
11 years of coding experience
10 years of employment as a software developer
Exchange studies, Exchange studies at Tecnológico de Monterrey
Laboratory training Molecular microbiology, Laboratory training Molecular microbiology at Virginia Tech
M.Sc. Biotechnology, M.Sc. Biotechnology at KTH Royal Institute of Technology
Doctor of Philosophy (Ph.D.) Cell and Molecular Biology, Doctor of Philosophy (Ph.D.) Cell and Molecular Biology at University of Houston
Macro and micro economics, Macro and micro economics at Stockholm University
Contributions:33 pushes, 2 branches in 4 years 11 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Philip Jonsson - Senior Director at Eli Lilly and Company